INDEMNIFICATION AGREEMENTIndemnification Agreement • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 2013 between Dance Biopharm Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations • California
MASTER AGREEMENT FOR JOINT VENTURE IN ASIAMaster Agreement for Joint Venture • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations • Hong Kong
This Master Agreement for a Joint Venture in Asia (“Agreement”) is made and entered into as of February 20, 2013, by and between Dance Biopharm Inc., a Delaware corporation, having its principal offices at 2 Mint Plaza #804, San Francisco, California 94103 (“Dance”) and Harmony Plus Holdings Limited, a Hong Kong corporation, having its principal offices at Room 1902, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong (“Harmony”). Dance and Harmony are together referred to herein as the “Parties” and each is variously referred to as a “Party”.
DANCE PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations • Delaware
The undersigned acknowledges that he, she or it has reviewed the representations and warranties contained in Annex 1 hereto and by his, her or its signature below hereby makes such representations and warranties to the Company. The undersigned further acknowledges that he, she or it, as a condition to the purchase of Warrant Shares, he, she or it, shall execute a counterpart signature page to each applicable Stockholder Agreement and be bound by the terms set forth therein.
CONFIDENTIAL LICENSE, DEVELOPMENT, COLLABORATION, AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN DANCE PHARMACEUTICALS, INC. AND AEROGEN LIMITED NOVEMBER 2010License, Development, Collaboration, and Commercialization Agreement • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations • New York
AMENDMENT TO DANCE BIOPHARM INC. Dated: December 10, 2013Equity Incentive Plan Amendment • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations
This Agreement amends the Dance Biopharm Inc. (formerly known as Dance Pharmaceuticals, Inc.) 2009 Equity Incentive Plan (the “Plan”). All capitalized terms not defined herein shall have the meanings set forth in the Plan.
ADDENDUM 1 to the License, Development, Collaboration and Commercialization Agreement COMMERCIAL SUPPLY AGREEMENT FOR DEVICE PROPRIETARY COMPONENTSCommercial Supply Agreement • January 9th, 2014 • Dance Biopharm, Inc. • Pharmaceutical preparations
This Addendum 1 (the “Addendum”, which expression includes any Appendices hereto) is to the LICENSE, DEVELOPMENT, COLLABORATION AND COMMERCIALIZATION AGREEMENT (the “License Agreement”) by and between Aerogen Limited, a private limited company incorporated in Ireland having its principal place of business at Galway Business Park, Dangan, Galway, Ireland (“Aerogen”) and Dance Biopharm, Inc., a Delaware, USA corporation having its principal place of business at 2 Mint Plaza, Suite 804, San Francisco, CA 94103, USA (“Dance”) (individually, a “Party” and jointly, “the Parties”) with an Effective Date of the 15th day of November, 2010. The effective date of this Addendum is 4th October, 2013 (the “Addendum Effective Date.”)
